Home / Healthcare / Pharmaceutical / U.S. Tardive Dyskinesia Therapeutics Market

U.S. Tardive Dyskinesia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug (Deutetrabenazine, Valbenazine, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Report Format: PDF | Published Date: Aug, 2023 | Report ID: FBI107826 | Status : Published
  • USA
  • 2022
  • 60
  • PRICE
  • $ 2850
    $ 3850
    $ 4850
    Buy Now

Healthcare Clients